BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29162614)

  • 1. Discovery and Validation of Pyridoxic Acid and Homovanillic Acid as Novel Endogenous Plasma Biomarkers of Organic Anion Transporter (OAT) 1 and OAT3 in Cynomolgus Monkeys.
    Shen H; Nelson DM; Oliveira RV; Zhang Y; Mcnaney CA; Gu X; Chen W; Su C; Reily MD; Shipkova PA; Gan J; Lai Y; Marathe P; Humphreys WG
    Drug Metab Dispos; 2018 Feb; 46(2):178-188. PubMed ID: 29162614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Elimination Pathways and the Feasibility of Endogenous Metabolites as Biomarkers of Organic Anion Transporter 1/3 Inhibition in Cynomolgus Monkeys.
    Liu R; Hao J; Zhao X; Lai Y
    Drug Metab Dispos; 2023 Jul; 51(7):844-850. PubMed ID: 37059471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the Validity of Pyridoxic Acid (PDA) as a Plasma-Based Endogenous Probe for OAT1 and OAT3 Function in Healthy Subjects.
    Shen H; Holenarsipur VK; Mariappan TT; Drexler DM; Cantone JL; Rajanna P; Singh Gautam S; Zhang Y; Gan J; Shipkova PA; Marathe P; Humphreys WG
    J Pharmacol Exp Ther; 2019 Jan; 368(1):136-145. PubMed ID: 30361237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters.
    Ahmad A; Ogungbenro K; Kunze A; Jacobs F; Snoeys J; Rostami-Hodjegan A; Galetin A
    CPT Pharmacometrics Syst Pharmacol; 2021 May; 10(5):467-477. PubMed ID: 33704919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers.
    Thakur A; Saradhi Mettu V; Singh DK; Prasad B
    Biochem Pharmacol; 2023 Dec; 218():115867. PubMed ID: 37866801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions.
    Willemin ME; Van Der Made TK; Pijpers I; Dillen L; Kunze A; Jonkers S; Steemans K; Tuytelaars A; Jacobs F; Monshouwer M; Scotcher D; Rostami-Hodjegan A; Galetin A; Snoeys J
    Clin Pharmacokinet; 2021 Sep; 60(9):1187-1199. PubMed ID: 33840062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 Inhibition.
    Tang J; Shen H; Zhao X; Holenarsipur VK; Mariappan TT; Zhang Y; Panfen E; Zheng J; Humphreys WG; Lai Y
    Drug Metab Dispos; 2021 Dec; 49(12):1063-1069. PubMed ID: 34599018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
    Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
    Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human organic anion transporter 2 is distinct from organic anion transporters 1 and 3 with respect to transport function.
    Henjakovic M; Hagos Y; Krick W; Burckhardt G; Burckhardt BC
    Am J Physiol Renal Physiol; 2015 Nov; 309(10):F843-51. PubMed ID: 26377792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Weak Organic Anion-Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans.
    Zhang Y; Holenarsipur VK; Kandoussi H; Zeng J; Mariappan TT; Sinz M; Shen H
    Drug Metab Dispos; 2020 Oct; 48(10):841-848. PubMed ID: 32723847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of Endogenous Compounds Applicable to Drug-Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans.
    Tsuruya Y; Kato K; Sano Y; Imamura Y; Maeda K; Kumagai Y; Sugiyama Y; Kusuhara H
    Drug Metab Dispos; 2016 Dec; 44(12):1925-1933. PubMed ID: 27638508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of
    Parvez MM; Shin HJ; Jung JA; Shin JG
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
    Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
    J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
    Xu G; Bhatnagar V; Wen G; Hamilton BA; Eraly SA; Nigam SK
    Kidney Int; 2005 Oct; 68(4):1491-9. PubMed ID: 16164626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning.
    Nigam AK; Li JG; Lall K; Shi D; Bush KT; Bhatnagar V; Abagyan R; Nigam SK
    J Biol Chem; 2020 Feb; 295(7):1829-1842. PubMed ID: 31896576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney.
    Tahara H; Shono M; Kusuhara H; Kinoshita H; Fuse E; Takadate A; Otagiri M; Sugiyama Y
    Pharm Res; 2005 Apr; 22(4):647-60. PubMed ID: 15846473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3.
    Granados JC; Richelle A; Gutierrez JM; Zhang P; Zhang X; Bhatnagar V; Lewis NE; Nigam SK
    J Biol Chem; 2021; 296():100575. PubMed ID: 33757768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
    Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
    Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions.
    Jia W; Du F; Liu X; Jiang R; Xu F; Yang J; Li L; Wang F; Olaleye OE; Dong J; Li C
    Drug Metab Dispos; 2015 May; 43(5):669-78. PubMed ID: 25710938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Assessment of Transporter-Mediated Drug-Drug Interactions Using a Probe Drug Cocktail in Cynomolgus Monkey.
    Kosa RE; Lazzaro S; Bi YA; Tierney B; Gates D; Modi S; Costales C; Rodrigues AD; Tremaine LM; Varma MV
    Drug Metab Dispos; 2018 Aug; 46(8):1179-1189. PubMed ID: 29880631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.